A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
GlaxoSmithKline
Eisai Inc.
Hutchmed
Cellestia Biotech AG
Bayer
Y-mAbs Therapeutics
Eisai Inc.
Celgene
Merck Sharp & Dohme LLC
Insmed Incorporated
INSYS Therapeutics Inc
Eli Lilly and Company
Eli Lilly and Company